NervGen Pharma Corp. Common stock

NGENNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
1.86 USD
↘ 0.15 (7.46%)AT CLOSE (11:59 AM EDT)
1.89
↗ 0.03 (1.61%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
1.89
↗ 0.03 (1.61%)
🔴Market: CLOSED
Open?$2.04
High?$2.05
Low?$1.85
Prev. Close?$2.01
Volume?1.1M
Avg. Volume?N/A
VWAP?$1.91
Bid / Ask
Bid?$1.86 × 5.6K
Ask?$1.88 × 300
Spread?$0.02
Midpoint?$1.87
Valuation & Ratios
Market Cap?197.5M
Shares Out?80.6M
Float?62.2M
Float %?78.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A

NervGen Pharma Corp. Common stock (NGEN) trades at $1.86 per share. Technical indicators currently signal "Strong Sell". This is driven by a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
Themes
Biotech - Drug Development›Neuroscience & CNS
Employees
9
Market Cap
197.5M
Industry
N/A
Website
www.nervgen.com
Listed
2019-03-25
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?2.51%Low
Short Interest?1.6M
Days to Cover?9.4
Free Float62.2M
Avg Daily Volume166.1K
Settlement Date2026-05-15
MarketsMoversWatchlist